乙醛
乙醇代谢
乙醇
化学
醇脱氢酶
新陈代谢
微粒体
酒
酒精性肝病
生物化学
脂肪生成
药物代谢
内科学
内分泌学
肝硬化
酶
生物
医学
作者
C S Lieber,Rolf Teschke,Yasushi Hasumura,Leonore M. DeCarli
出处
期刊:PubMed
日期:1975-10-01
卷期号:34 (11): 2060-74
被引量:49
摘要
Hepatic metabolism of ethanol to acetaldehyde by the alcohol dehydrogenase pathway is associated with the generation of reducing equivalents as NADH. Conversely, reducing equivalents are consumed when ethanol oxidation is catalyzed by the NADPH dependent microsomal ethanol oxidizing system. Since the major fraction of ethanol metabolism proceeds via alcohol dehydrogenase and since the oxidation of acetaldehyde also generates NADH, an excess of reducing equivalents is produced. This explains a variety of effects following acute ethanol administration, including hyperlactacidemia, hyperuricemia, enhanced lipogenesis and depressed lipid oxidation. To the extent that ethanol is oxidized by the alternate microsomal ethanol oxidizing system pathway, it slows the metabolism of other microsomal substrates. Following chronic ethanol consumption, adaptive microsomal changes prevail, which include enhanced ethanol and drug metabolism, and increased lipoprotein production. Severe hepatic lesions (alcoholic hepatitis and cirrhosis) develop after prolonged ethanol consumption in baboons. These injurious alterations are not prevented by nutritionally adequate diets and can therefore be ascribed to ethanol rather than to dietary inadequacy.
科研通智能强力驱动
Strongly Powered by AbleSci AI